Abstract
Thomas Novotny reflects on new research by Stanton Glantz and colleagues and the implications of their findings for engaging the tobacco industry on tobacco product regulation.
MeSH terms
-
Advisory Committees / legislation & jurisprudence*
-
Harm Reduction*
-
Humans
-
Professional Misconduct*
-
Smoking / adverse effects*
-
Smoking / legislation & jurisprudence*
-
Tobacco Industry / legislation & jurisprudence*
-
Tobacco Products / adverse effects*
-
Truth Disclosure*
-
United States Food and Drug Administration / legislation & jurisprudence*
Grants and funding
No specific funding was received for writing this article.